NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 254 filers reported holding NOVAVAX INC in Q4 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,124 | -22.3% | 984 | -20.3% | 0.00% | – |
Q2 2023 | $9,169 | +7.2% | 1,234 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $8,552 | -32.6% | 1,234 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $12,686 | -42.3% | 1,234 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $22,000 | -81.4% | 1,234 | -40.4% | 0.00% | -66.7% |
Q2 2022 | $118,000 | -11.3% | 2,070 | +14.4% | 0.01% | 0.0% |
Q1 2022 | $133,000 | +15.7% | 1,809 | +124.7% | 0.01% | +50.0% |
Q4 2021 | $115,000 | +66.7% | 805 | +111.8% | 0.00% | +33.3% |
Q3 2021 | $69,000 | -15.9% | 380 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $82,000 | -40.6% | 380 | -34.9% | 0.00% | -25.0% |
Q1 2021 | $138,000 | +500.0% | 584 | +77.0% | 0.00% | +300.0% |
Q4 2020 | $23,000 | +109.1% | 330 | +230.0% | 0.00% | 0.0% |
Q3 2020 | $11,000 | -78.8% | 100 | -85.2% | 0.00% | -66.7% |
Q2 2020 | $52,000 | +136.4% | 675 | -61.4% | 0.00% | +200.0% |
Q1 2020 | $22,000 | +2100.0% | 1,750 | +753.7% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 205 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | – | 205 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |